Does INFLIXIMAB Cause Obesity? 1,536 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,536 reports of Obesity have been filed in association with INFLIXIMAB (Renflexis). This represents 1.1% of all adverse event reports for INFLIXIMAB.
1,536
Reports of Obesity with INFLIXIMAB
1.1%
of all INFLIXIMAB reports
886
Deaths
1,343
Hospitalizations
How Dangerous Is Obesity From INFLIXIMAB?
Of the 1,536 reports, 886 (57.7%) resulted in death, 1,343 (87.4%) required hospitalization, and 1,013 (66.0%) were considered life-threatening.
Is Obesity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 1,536 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Obesity?
RISPERIDONE (3,039)
PREDNISONE (1,880)
METHOTREXATE (1,876)
ADALIMUMAB (1,780)
TOCILIZUMAB (1,630)
ABATACEPT (1,605)
HYDROXYCHLOROQUINE (1,532)
SULFASALAZINE (1,455)
ETANERCEPT (1,407)
RITUXIMAB (1,392)
Which INFLIXIMAB Alternatives Have Lower Obesity Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT